These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 2761915

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. CA 125, NB/70K, and lipid-associated sialic acid in monitoring uterine papillary serous carcinoma.
    Tseng PC, Sprance HE, Carcangiu ML, Chambers JT, Schwartz PE.
    Obstet Gynecol; 1989 Sep; 74(3 Pt 1):384-7. PubMed ID: 2761916
    [Abstract] [Full Text] [Related]

  • 4. [Serum lipid-associated sialic acid (LSA) in diagnosing and monitoring ovarian cancer].
    Yue K, Bian M, Zhu D, Liu W, Siu S.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Apr; 17(2):128-32. PubMed ID: 7656393
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer.
    Koelbl H, Schieder K, Neunteufel W, Bieglmayer C.
    Neoplasma; 1989 Apr; 36(4):473-8. PubMed ID: 2770933
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Evaluation on non invasive diagnostic tests for the second look in epithelial ovarian cancer].
    García Enguídanos A, Crespo Azanza E, Díaz Recaséns J, Lobo Samper F, Jorge Herrero JA, Sáinz de la Cuesta Abbad R.
    Rev Clin Esp; 1998 Aug; 198(8):502-5. PubMed ID: 9774878
    [Abstract] [Full Text] [Related]

  • 11. [Computed tomography and tumor markers as diagnostic alternatives to second-look surgery in the treatment of malignant ovarian tumors].
    La Fianza A, Campani R, Dore R, Babilonti L, Torretta L.
    Radiol Med; 1992 Apr; 83(4):374-82. PubMed ID: 1603993
    [Abstract] [Full Text] [Related]

  • 12. The importance of polyamine determination in monitoring malignant gynaecological tumours.
    Szarka G, Pulay T, Csömör S, Tran-Phuong-Mai, Schumann B.
    Acta Chir Hung; 1988 Apr; 29(4):365-72. PubMed ID: 3239336
    [Abstract] [Full Text] [Related]

  • 13. Predictive value of the combined serum CA 125 and TPS during chemotherapy and before second-look laparotomy in epithelial ovarian cancer.
    Senapad S, Neungton S, Thirapakawong C, Suphanit I, Hangsubcharoen M, Thamintorn K.
    Anticancer Res; 2000 Apr; 20(2B):1297-300. PubMed ID: 10810438
    [Abstract] [Full Text] [Related]

  • 14. Correlation of platelet count with second-look laparotomy results and disease progression in patients with advanced epithelial ovarian cancer.
    Bozkurt N, Yuce K, Basaran M, Kose F, Ayhan A.
    Obstet Gynecol; 2004 Jan; 103(1):82-5. PubMed ID: 14704249
    [Abstract] [Full Text] [Related]

  • 15. Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer.
    Baron AT, Lafky JM, Boardman CH, Balasubramaniam S, Suman VJ, Podratz KC, Maihle NJ.
    Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):129-37. PubMed ID: 10067810
    [Abstract] [Full Text] [Related]

  • 16. Tumor markers in epithelial ovarian cancer. Clinical applications.
    Hempling RE.
    Obstet Gynecol Clin North Am; 1994 Mar; 21(1):41-61. PubMed ID: 8015766
    [Abstract] [Full Text] [Related]

  • 17. Predictive and prognostic values of cancer-associated serum antigen (CASA) and cancer antigen 125 (CA 125) levels prior to second-look laparotomy for ovarian cancer.
    Kierkegaard O, Mogensen O, Mogensen B, Jakobsen A.
    Gynecol Oncol; 1995 Nov; 59(2):251-4. PubMed ID: 7590482
    [Abstract] [Full Text] [Related]

  • 18. [Predictive value of the tumor marker combination CA-125 and beta-2-microglobulin in ovarian cancer].
    Hernádi Z, Molnár V, Juhász B, Pólka R, Margitai B.
    Zentralbl Gynakol; 1992 Nov; 114(1):6-9. PubMed ID: 1585745
    [Abstract] [Full Text] [Related]

  • 19. Importance of serum sialic acid and lactate dehydrogenase in diagnosis and treatment monitoring of cervical cancer patients.
    Patel PS, Rawal GN, Balar DB.
    Gynecol Oncol; 1993 Sep; 50(3):294-9. PubMed ID: 8406190
    [Abstract] [Full Text] [Related]

  • 20. [Serum lipid-bound sialic acid as a marker in lung cancer patients].
    Iwahashi N.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Dec; 28(12):1599-607. PubMed ID: 2077205
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.